Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?

被引:0
|
作者
Qiang Zhou [1 ]
Hao Cai [1 ]
Ming-Hao Xu [1 ]
Yao Ye [2 ]
Xiao-Long Li [1 ]
Guo-Ming Shi [1 ]
Cheng Huang [1 ]
Xiao-Dong Zhu [1 ]
Jia-Bin Cai [1 ]
Jian Zhou [1 ]
Jia Fan [1 ]
Yuan Ji [2 ]
Hui-Chuan Sun [1 ]
Ying-Hao Shen [1 ]
机构
[1] Department of Liver Surgery,Liver Cancer Institute,Zhongshan Hospital,and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education),Fudan University
[2] Department of Pathology,Zhongshan Hospital,Fudan University
基金
上海市自然科学基金;
关键词
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
Background:The incidence of combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma(c HCC-ICC) is relatively low,and the knowledge about the prognosis of c HCC-ICC remains obscure.In the study,we aimed to screen existing primary liver cancer staging systems and shed light on the prognosis and risk factors for c HCC-ICC.Methods:We retrospectively reviewed 206 c HCC-ICC patients who received curative surgical resection from April 1999 to March 2017.The correlation of survival measures with the histological types or with tumor staging systems was determined and predictive values of tumor staging systems with c HCC-ICC prognosis were compared.Results:The histological type was not associated with overall survival(OS)(P = 0.338) or disease-free survival(DFS)(P = 0.843) of patients after curative surgical resection.BCLC,TNM for HCC,and TNM for ICC stages correlated with both OS and DFS in c HCC-ICC(all P < 0.05).The predictive values of TNM for HCC and TNM for ICC stages were similar in terms of predicting postoperative OS(P = 0.798) and DFS(P = 0.191) in c HCC-ICC.TNM for HCC was superior to BCLC for predicting postoperative OS(P = 0.022) in c HCC-ICC.Conclusion:The TNM for HCC staging system should be prioritized for clinical applications in predicting c HCC-ICC prognosis.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [11] Clinicopathologic and treatment characteristics of mixed hepatocellular carcinoma-intrahepatic cholangiocarcinoma (HCC-ICC)
    Ozer, Muhammet
    Goksu, Suleyman Yasin
    Sahin, Ilyas
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [12] Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
    Yoon, Young-In
    Hwang, Shin
    Lee, Young-Joo
    Kim, Ki-Hun
    Ahn, Chul-Soo
    Moon, Deok-Bog
    Ha, Tae-Yong
    Song, Gi-Won
    Jung, Dong-Hwan
    Lee, Jong-Woo
    Hong, Seung-Mo
    Yu, Eun Sil
    Lee, Sung-Gyu
    JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (02) : 411 - 420
  • [13] Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
    Young-In Yoon
    Shin Hwang
    Young-Joo Lee
    Ki-Hun Kim
    Chul-Soo Ahn
    Deok-Bog Moon
    Tae-Yong Ha
    Gi-Won Song
    Dong-Hwan Jung
    Jong-Woo Lee
    Seung-Mo Hong
    Eun Sil Yu
    Sung-Gyu Lee
    Journal of Gastrointestinal Surgery, 2016, 20 : 411 - 420
  • [14] Double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma
    Hu, Yi-Hsuan
    Hou, Yi-Chou
    FORMOSAN JOURNAL OF SURGERY, 2020, 53 (06) : 236 - 239
  • [15] Gallbladder Metastatic Combined Hepatocellular Carcinoma and Cholangiocarcinoma Without Primary Intrahepatic Tumor
    Huang, Yang
    Liu, Guang Jian
    Lu, Ming De
    Liao, Bing
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (09) : 2733 - 2735
  • [16] A case of primary carcinosarcoma of the liver with combined hepatocellular carcinoma and cholangiocarcinoma
    Takashi Ofuchi
    Katsunori Imai
    Yosuke Nakao
    Shigeki Nakagawa
    Yuta Shiraishi
    Rikako Kato
    Rumi Itoyama
    Toshihiko Yusa
    Takaaki Higashi
    Hiromitsu Hayashi
    Tsuguharu Asato
    Yo-ichi Yamashita
    Yoshiki Mikami
    Hideo Baba
    Clinical Journal of Gastroenterology, 2021, 14 : 1476 - 1483
  • [17] A case of primary carcinosarcoma of the liver with combined hepatocellular carcinoma and cholangiocarcinoma
    Ofuchi, Takashi
    Imai, Katsunori
    Nakao, Yosuke
    Nakagawa, Shigeki
    Shiraishi, Yuta
    Kato, Rikako
    Itoyama, Rumi
    Yusa, Toshihiko
    Higashi, Takaaki
    Hayashi, Hiromitsu
    Asato, Tsuguharu
    Yamashita, Yo-ichi
    Mikami, Yoshiki
    Baba, Hideo
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (05) : 1476 - 1483
  • [18] Gallbladder Metastatic Combined Hepatocellular Carcinoma and Cholangiocarcinoma Without Primary Intrahepatic Tumor
    Yang Huang
    Guang Jian Liu
    Ming De Lu
    Bing Liao
    Digestive Diseases and Sciences, 2013, 58 : 2733 - 2735
  • [19] Mucin in primary liver carcinomas: Combined hepatocellular cholangiocarcinoma or variant hepatocellular carcinoma
    Hirota, S
    Nomoto, M
    Hosobe, S
    Aoyagi, Y
    Asakura, H
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 10 (01): : 12 - 16
  • [20] DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma
    Bai, Yi
    Tong, Wen
    Xie, Fucun
    Zhu, Liuyang
    Wu, Hao
    Shi, Rui
    Wang, Lianjiang
    Yang, Long
    Liu, Zhisong
    Miao, Fei
    Zhao, Qiang
    Zhang, Yaming
    AGING-US, 2021, 13 (13): : 17592 - 17606